Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can drospirenone with 17-β estradiol safely reduce blood pressure in hypertensive postmenopausal women?

Nature Clinical Practice Endocrinology & Metabolism volume 1, pages 72–73 (2005)Cite this article

boxed-textPreston RA et al. (2005) Effects of drospirenone/17-β estradiol on blood pressure and potassium balance in hypertensive postmenopausal women. Am J Hypertens 18: 797–804

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Manson J et al. (2003) Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349: 523–534

    Article  CAS  Google Scholar 

  2. Pitt B et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341: 709–717

    Article  CAS  Google Scholar 

  3. Pitt B et al. (2001) The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther 15: 79–87

    Article  CAS  Google Scholar 

  4. Rosendorff C (2005) Progestins and potassium. Am J Hypertens 18: 741–743

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Post-Doctoral Fellow in Nephrology, MU Diabetes and Cardiovascular Center and Associate Dean for Clinical Research at the University of Missouri, USA

    Adam Whaley-Connell

  2. Resident Physician in Internal Medicine, MU Diabetes and Cardiovascular Center and Associate Dean for Clinical Research at the University of Missouri, USA

    John Palmer

  3. the Director of the MU Diabetes and Cardiovascular Center and Associate Dean for Clinical Research at the University of Missouri, USA

    James R Sowers

Authors
  1. Adam Whaley-Connell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Palmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James R Sowers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam Whaley-Connell.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Whaley-Connell, A., Palmer, J. & Sowers, J. Can drospirenone with 17-β estradiol safely reduce blood pressure in hypertensive postmenopausal women?. Nat Rev Endocrinol 1, 72–73 (2005). https://doi.org/10.1038/ncpendmet0029

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0029

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing